時富金融服務集團(00510.HK)上半年淨虧損收窄32.34%至1902.9萬港元
格隆匯8月30日丨時富金融服務集團(00510.HK)發佈中期業績,截至2021年6月30日止6個月,實現總收益5577.2萬港元,同比增長10.44%;公司擁有人應占虧損1902.9萬港元,同比收窄32.34%;基本每股虧損7.69港仙。
為應對疫情,公司遵循董事會批准的新冠疫情業務連續性計劃當中的業務連續性流程。該業務連續性計劃將員工的健康及福祉作為首要考慮因素,為非關鍵及易受疫情影響的員工實施在家工作安排。由於公司基於新冠疫情業務連續性計劃採取有效的紓緩措施,新冠病毒疫情對公司的財務業績影響有限。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.